- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07595484
A Prospective Comparative Study of Dry vs Wet Temporalis Fascia Graft in Tympanoplasty
This study was conducted to compare two methods of using temporalis fascia graft in tympanoplasty, namely wet temporalis fascia graft and dry temporalis fascia graft. Tympanoplasty is an ear surgery performed to repair a hole in the ear drum and to improve hearing in patients with chronic otitis media. Temporalis fascia is a thin layer of tissue taken from the area over the temple muscle and is commonly used as graft material for repair of the ear drum.
The study included adult patients aged 18 to 60 years who had chronic otitis media with inactive mucosal disease, a large central perforation of the ear drum, and conductive hearing loss confirmed on pure-tone audiometry. Patients were assigned to one of two treatment groups. One group underwent tympanoplasty using a wet temporalis fascia graft, while the other group underwent tympanoplasty using a dry temporalis fascia graft.
The main purpose of the study was to assess whether one graft preparation technique gave better surgical and hearing outcomes than the other. The outcomes were assessed three months after surgery. Hearing improvement was measured by comparing the air-bone gap before and after surgery on pure-tone audiometry. Graft success was assessed by otoscopic examination to determine whether the graft had healed properly, remained in correct position, and closed the ear drum perforation. Complete air-bone gap closure was also assessed as an additional hearing outcome.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Shaikh Zayed Medical college/hospital, Lahore
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged 18 to 60 years.
- Patients of either gender.
- Patients diagnosed with chronic otitis media.
- Patients with inactive mucosal disease, with no active ear discharge.
- Patients with a large central perforation of the tympanic membrane.
- Tympanic membrane perforation persisting for at least 6 weeks.
- Patients with pure conductive hearing loss confirmed on pure-tone audiometry.
Exclusion Criteria:
- Patients with active otitis media, acute infection, or active ear discharge.
- Patients with tympanosclerosis or ossicular necrosis affecting ossicular chain mobility.
- Patients with a history of previous ear surgery that could affect tympanoplasty outcomes, such as ossiculoplasty or mastoidectomy, except prior myringotomy.
- Patients with sensorineural hearing loss or mixed hearing loss.
- Patients with conditions impairing wound healing or postoperative care compliance, including uncontrolled diabetes mellitus or immunodeficiency disorders.
- Patients with confirmed Eustachian tube dysfunction.
- Patients with active infection in the throat, nose, paranasal sinuses, or oral cavity.
- Patients with bleeding disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group Wet Temporalis Fascia Graft
Participants in this group underwent tympanoplasty using the wet temporalis fascia graft technique for repair of tympanic membrane perforation.
|
Tympanoplasty was performed using a wet temporalis fascia graft to repair the tympanic membrane perforation.
Postoperative assessment was performed at 3 months using otoscopic examination and pure-tone audiometry
|
|
Active Comparator: Group Dry Temporalis Fascia Graft
Participants in this group underwent tympanoplasty using the dry temporalis fascia graft technique for repair of tympanic membrane perforation.
|
Tympanoplasty was performed using a dry temporalis fascia graft to repair the tympanic membrane perforation.
Postoperative assessment was performed at 3 months using otoscopic examination and pure-tone audiometry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean hearing gain after tympanoplasty
Time Frame: 3 months after surgery
|
Mean hearing gain was measured by comparing the preoperative and postoperative air-bone gap on pure-tone audiometry.
The air-bone gap was assessed at 500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz.
Mean hearing gain was calculated by subtracting the postoperative air-bone gap from the preoperative air-bone gap.
A greater reduction in air-bone gap indicated better hearing improvement after tympanoplasty.
|
3 months after surgery
|
|
Graft uptake rate after tympanoplasty
Time Frame: 3 months after surgery
|
Graft uptake rate was assessed by otoscopic examination.
A successful graft uptake was defined as an intact and correctly positioned graft with closure of the tympanic membrane perforation, without evidence of graft rejection or active infection.
|
3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complete Air-Bone Gap Closure
Time Frame: 3 months after surgery
|
Complete air-bone gap closure was defined as a postoperative air-bone gap of 10 dB or less on pure-tone audiometry.
This outcome was used to assess clinically meaningful improvement in conductive hearing loss after tympanoplasty.
|
3 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hafiz Adil Ikram, Shaikh Zayed Hospital, Lahore
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ShaikhZayedH2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tympanic Membrane Perforation
-
Astellas Pharma Global Development, Inc.TerminatedChronic Tympanic Membrane PerforationUnited States
-
D. Bradley Welling, MD, PhDNobelpharmaSuspendedChronic Tympanic Membrane PerforationUnited States
-
Abd-Elazeem Abd-Elhameed ElbakryCompletedTympanum; PerforationEgypt
-
Cook Research IncorporatedCompletedTympanic Membrane Perforation | Eardrum PerforationUnited States, United Kingdom
-
Hospital Felicio RochoRecruitingBarotrauma;Ear | Tympanum; PerforationBrazil
-
Central Adelaide Local Health Network IncorporatedUniversity of AdelaideRecruitingSurgery | Otitis Media | Tympanic Membrane Perforation | Tympanic Membrane InflammationAustralia
-
University of British ColumbiaCompleted
-
HaEmek Medical Center, IsraelNot yet recruitingTympanic Membrane Perforation
-
Grace Medical, Inc.Recruiting
-
Henry Ford Health SystemWithdrawn
Clinical Trials on Wet Temporalis Fascia Graft Tympanoplasty
-
Lady Reading Hospital, PakistanCompletedHearing Loss,ConductivePakistan
-
Mansoura UniversityCompleted
-
Mohamed Soltan NadaCompleted
-
Henry Ford Health SystemWithdrawn
-
Henry Ford Health SystemWithdrawnOtologic DiseaseUnited States
-
Assiut UniversityNot yet recruitingTympanic Membrane Perforation
-
Shaikh Zayed Hospital, LahoreCompletedConductive Hearing Loss | Tympanic Membrane Perforation | Chronic Otitis MediaPakistan
-
Baylor College of MedicineUnknown
-
Kafrelsheikh UniversityNot yet recruiting
-
Mohammad Sadegh Bagheri BaghdashtCompletedTympanic Membrane Perforation